Mutations in the Cystic Fibrosis Transmembrane Regulator Gene andIn VivoTransepithelial Potentials-Reference-Cited by-同舟云学术

Mutations in the Cystic Fibrosis Transmembrane Regulator Gene andIn VivoTransepithelial Potentials

Published:2006-10 Issue:7 Volume:174 Page:787-794
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Wilschanski Michael,Dupuis Annie,Ellis Lynda,Jarvi Keith,Zielenski Julian,Tullis Elizabeth,Martin Sheelagh,Corey Mary,Tsui Lap-Chee,Durie Peter

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference49 articles.

1. The Relation between Genotype and Phenotype in Cystic Fibrosis — Analysis of the Most Common Mutation (ΔF508)

2. Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis

3. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis.Am J Hum Genet1992;50:1178–1184.

4. Tsui LC. The spectrum of cystic fibrosis mutations.Trends Genet1992;8: 392–398.

5. Genotype and Phenotype in Cystic Fibrosis

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging as a loss of morphostatic information: A developmental bioelectricity perspective;Ageing Research Reviews;2024-06

2. ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals;Journal of Cystic Fibrosis;2024-05

3. Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators;International Journal of Molecular Sciences;2023-08-29

4. Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis;Cureus;2023-08-16

5. Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years;Frontiers in Pharmacology;2023-05-30